Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

April 27, 2022Open Access

CXCR2 inhibition enables NASH-HCC immunotherapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

CXCR2-inhibition induces reprogramming of the tumour immune microenvironment that promotes ICI in NASH-HCC.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

CXCR2 inhibition enables NASH-HCC immunotherapy | Synapse

Cite This Study

Leslie et al. (Wed,) studied this question.

synapsesocial.com/papers/69db23357a67537a8ba3d061 https://doi.org/https://doi.org/10.1136/gutjnl-2021-326259

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Dendritic Cells and Their Role in Immunotherapy2020 · 488 citations
2Identification of an Early Unipotent Neutrophil Progenitor with Pro-tumoral Activity in Mouse and Human Bone Marrow2018 · 215 citations
3Granzyme B production distinguishes recently activated CD8+ memory cells from resting memory cells2007 · 75 citations
4Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 112,910 citations
5Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis2020 · 81 citations